OSTEOPOROSIS (Eng/Kor) for NCLEX
2026. 5. 18. 05:12ㆍIn Canada/nursing study
반응형
OSTEOPOROSIS
1. Definition | 정의
EN
Osteoporosis is a metabolic bone disease characterized by low bone mass, deterioration of bone tissue, and increased bone fragility, leading to a higher risk of fractures.
KR
골다공증은 골밀도 감소와 골 조직 약화로 인해 뼈가 약해지고 쉽게 골절되는 대사성 골질환이다.
2. Causes | 원인
Primary
- Aging
- Postmenopausal estrogen deficiency (women)
- Age-related testosterone decline (men)
Secondary
- Long-term corticosteroid use
- Hyperthyroidism or overtreated hypothyroidism
- Chronic kidney disease
- Malabsorption (celiac, Crohn’s)
- Alcohol abuse, smoking
- Anticonvulsants, PPIs, heparin
- Endocrine disorders (Cushing’s, hyperparathyroidism)
3. Risk Factors | 위험요인
EN
- Age ≥ 65
- Female, postmenopausal
- Family history
- Small body frame, low BMI
- Smoking
- Excess alcohol
- Low calcium/Vitamin D intake
- Sedentary lifestyle
- Long-term steroid therapy
KR
- 65세 이상
- 여성, 폐경
- 골다공증 가족력
- 저체중, 작은 체형
- 흡연
- 과도한 음주
- 칼슘·비타민D 부족
- 운동 부족
- 장기 스테로이드 복용
4. Pathophysiology | 병태생리
EN
Imbalance between bone resorption (osteoclasts) and bone formation (osteoblasts).
→ Resorption > formation → Bone becomes porous and fragile.
KR
파골세포(뼈 흡수) > 조골세포(뼈 형성) 불균형
→ 뼈가 속이 비고 약해져 골절 위험 증가
5. Clinical Manifestations | 증상
- Often asymptomatic until fracture
- Height loss
- Kyphosis ("dowager’s hump")
- Back pain
- Fragility fractures (wrist, hip, vertebrae)
6. Complications | 합병증
- Vertebral compression fractures
- Hip fractures → immobility, death risk ↑
- Chronic pain
- Decreased mobility
- Respiratory issues due to kyphosis
- Poor quality of life
7. Diagnostics | 진단 검사
EN
- DEXA scan: T-score
- Normal: ≥ –1
- Osteopenia: –1 to –2.5
- Osteoporosis: ≤ –2.5
- Serum vitamin D level
- Calcium, phosphorus
- Thyroid/parathyroid tests
- X-ray (if fracture suspected)
KR
- 골밀도 검사(DEXA)
- 정상: ≥ –1
- 골감소증: –1 ~ –2.5
- 골다공증: ≤ –2.5
- 비타민 D, 칼슘, 인 수치
- 갑상선·부갑상선 기능 검사
- X-ray (골절 의심 시)
8. Treatment | 치료
A. Non-pharmacologic (비약물)
EN
- Weight-bearing exercise (walking, stairs)
- Muscle-strengthening exercises
- Fall prevention
- Adequate calcium & Vitamin D
- Quit smoking
- Limit alcohol
- Home safety assessment
KR
- 체중 부하 운동(걷기, 계단)
- 근력 강화 운동
- 낙상 예방
- 칼슘·비타민 D 충분히
- 금연
- 음주 제한
- 가정 낙상 위험 점검
B. Pharmacologic (약물)
1. Bisphosphonates (first-line)
- Alendronate
- Risedronate
- Ibandronate
- Zoledronic acid (IV yearly)
Key teaching:
- Take in AM with full glass of water
- Stay upright for 30–60 min
- Prevent esophagitis
2. RANKL inhibitor
Denosumab (Prolia)
- SC injection every 6 months
- Risk of hypocalcemia
3. Selective estrogen receptor modulators
Raloxifene
- ↓ vertebral fractures
- Risk: DVT, hot flashes
4. Hormone therapy
Estrogen (postmenopausal) – limited use due to risk
Testosterone (in men with deficiency)
5. Parathyroid hormone analogs (anabolic)
Teriparatide, Abaloparatide
- Stimulate bone formation
- Used for severe osteoporosis
6. Calcitonin
- Nasal spray
- Less effective; used for acute pain in compression fractures
9. Nursing Considerations | 간호중재
EN
- Assess fall risk
- Encourage weight-bearing exercise
- Ensure adequate calcium/Vitamin D intake
- Teach correct bisphosphonate use
- Monitor for jaw osteonecrosis (dental exams)
- Assess pain, posture, height changes
- Provide home safety resources
- Monitor kidney function with bisphosphonates
KR
- 낙상 위험 사정
- 체중 부하 운동 격려
- 칼슘·비타민 D 섭취 지도
- 비스포스포네이트 복용법 교육
- 턱뼈 괴사 감시(치과 검진)
- 통증·자세·신장 변화 관찰
- 가정 내 낙상 위험 점검
- 신장 기능 모니터링
10. Patient Teaching | 환자 교육
EN
- Calcium 1200 mg/day (diet + supplement)
- Vitamin D 800–1000 IU/day
- Exercise routinely
- Quit smoking
- Avoid excessive caffeine
- Prevent falls (lighting, grab bars, proper shoes)
- Report new back pain → possible vertebral fracture
KR
- 칼슘 하루 1200 mg
- 비타민 D 800–1000 IU
- 규칙적 운동
- 금연
- 카페인 과다 섭취 금지
- 낙상 예방(손잡이 설치, 조명 밝게)
- 갑작스러운 허리 통증 즉시 보고
반응형
'In Canada > nursing study' 카테고리의 다른 글
| SCURVY (Vitamin C Deficiency) (Eng/Kor) for NCLEX (0) | 2026.05.22 |
|---|---|
| CYSTIC FIBROSIS (CF) (Eng/Kor) for NCLEX (0) | 2026.05.20 |
| SICKLE CELL DISEASE (SCD) (Eng/Kor) for NCLEX (0) | 2026.05.16 |
| Azotemia (Eng/Kor) for NCLEX (0) | 2026.05.14 |
| Staphylococcemia (Eng/Kor) for NCLEX (0) | 2026.05.12 |